Most common adverse reactions include: anorexia, epigastric discomfort, nausea, vomiting, diarrhea, depression, dizziness, vertigo, rash, hypercholesterolemia, hypertriglyceridemia, hypothyroidism, and decreased blood free testosterone in males.
from FDA,2024.01
Regarding the clinical application and medication specifications of mitotane, th···【more】
Release date:2025-05-08Recommended:451
Understanding drug properties and treatment costs is an important reference for ···【more】
Release date:2025-05-07Recommended:469
The potential impact of medication is a core concern that patients must focus on···【more】
Release date:2025-05-07Recommended:456
Mitotane is a drug dedicated to the treatment of adrenocortical carcinoma (inope···【more】
Release date:2024-08-20Recommended:525
Mitotaneis a drug used to treat inoperable adrenal cortical carcinoma, adrenal h···【more】
Release date:2024-08-20Recommended:468
Mitotaneis a highly potent antineoplastic drug specifically designed to treat in···【more】
Release date:2024-08-19Recommended:511